ETF Managers Group, LLC Oncocyte Corp Transaction History

ETF Managers Group, LLC

  • $2.78 Billion
  • Q1 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$1.38 - $2.63 $217,947 - $415,363
-157,933 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$1.2 - $1.89 $14,739 - $23,214
12,283 Added 8.43%
157,933 $226,000
Q2 2020

Aug 14, 2020
SELL
$1.91 - $3.45 $3,161 - $5,709
-1,655 Reduced 1.12%
145,650 $470,000
Q1 2020

May 14, 2020
BUY
$1.76 - $3.02 $23,041 - $39,537
13,092 Added 9.75%
147,305 $349,000
Q4 2019

Feb 14, 2020
BUY
$1.51 - $2.27 $202,661 - $304,663
134,213 New
134,213 $286,000

Others Institutions Holding OCX

# of Institutions
2
Shares Held
352K
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $337M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email